Eosinophilic Colitis in a Patient with Acute Myeloid Leukemia after Allogeneic Bone Marrow Transplantation
スポンサーリンク
概要
- 論文の詳細を見る
- 2003-07-01
著者
-
Shimada Takahiro
近畿大学 内科学 血液腎臓膠原病内科
-
ANDO Kiyoshi
Tokai University
-
Kanamaru A
Department Of Hematology Kinki University School Of Medicine
-
Kanamaru Akihisa
Division Of Hematology Nephrology And Rheumatology Department Of Internal Medicine Kinki University
-
SHIMADA Takahiro
Division of Hematology, Nephrology and Rheumatology, Department of Internal Medicine, Kinki Universi
-
MIYATAKE Junichi
Division of Hematology, Nephrology and Rheumatology, Department of Internal Medicine, Kinki Universi
-
Shimada Takahiro
Division Of Hematology Nephrology And Rheumatology Department Of Internal Medicine Kinki University
-
Kikuchi Ako
Department Of Hematology/oncology Tokai University School Of Medicine
-
Kikuchi Ako
Tokai University
-
Ashida Takashi
Third Department Of Internal Medicine Kinki University School Of Medicine
-
Ashida Takashi
Division Of Hematology Nephrology And Rheumatology Department Of Internal Medicine Kinki University
-
Ashida Takashi
Power Reactor And Nuclear Fuel Development Corp.
-
KAWANISHI Kazunobu
Division of Hematology, Nephrology and Rheumatology, Department of Internal Medicine, Kinki Universi
-
Miyatake Jun-ichi
Division Of Hematology Nephrology And Rheumatology Department Of Internal Medicine Kinki University
-
Shimada Takahiro
Division Of Hematology Nephrology And Rheumatology Department Of Internal Medicine Kinki University
-
Miyatake J
Kinki Univ. School Of Medicine Osaka Jpn
-
Kanamaru Akihisa
Division Of Hematology And Oncology Department Of Medicine Tokai University School Of Medicine
-
Kawanishi Kazunobu
Division Of Hematology Nephrology And Rheumatology Department Of Internal Medicine Kinki University
-
Miyatake Junichi
Division Of Hematology Nephrology And Rheumatology Department Of Internal Medicine Kinki University
-
Ando Kiyoshi
Department Of Hematology And Oncology Tokai University
-
Ashida Takashi
Division Of Hematology Department Of Internal Medicine Kinki University Faculty Of Medicine
-
Shimada Takahiro
Division Of Hematology Department Of Internal Medicine Kinki University Faculty Of Medicine
-
Ashida Takashi
Division of Hematology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Kinki University, Japan
-
Kawanishi Kazunobu
Division of Hematology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Kinki University, Japan
-
Miyatake Junichi
Division of Hematology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Kinki University, Japan
-
SHIMADA Takahiro
Division of Hematology and Rheumatology, Department of Internal Medicine, Kinki University Faculty of Medicine
関連論文
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Persistence of derivative chromosome 22 after achieving a major molecular response in chronic myeloid leukemia with a cryptic BCR-ABL1 fusion gene
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Non-hematopoietic Mesenchymal Stem Cells can be Mobilized and Differentiate into Cardiomyocytes after Myocardial Infarction(Development and Differentiation 3 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Transplanted Bone Marrow Stem Cells Move to the Infarcted Myocardium and Regenerate the Heart
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- A phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura